Evidence map›Paper›PMID 42332721›Full record

ArticleCell communication and signaling : CCS2026

Structural insights into the specificity of adaptor proteins Dok5 and Dok6 Docking to Trk receptors.

Yingyao Wu, Xiaojiao Sun, Hongyue Chen, Bin Yin, Lin Hou, Boqin Qiang, Pengcheng Shu, Xiaozhong Peng

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yingyao Wu *State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China.
Xiaojiao Sun *State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China.
Hongyue ChenState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China.
Bin YinState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China.
Lin HouState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China.
Boqin QiangState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China.
Pengcheng ShuState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China. pengcheng_shu@ibms.pumc.edu.cn.
Xiaozhong PengState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry & Molecular Biology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China. pengxiaozhong@pumc.edu.cn.ORCID https://orcid.org/0000-0002-9592-9554

Funding

Beijing Natural Science Foundation 5262021CAMS Innovation Fund for Medical Sciences 2021-1-I2M-019CAMS Innovation Fund for Medical Sciences 2021-1-I2M-024National Key Research and Development Program of China 2022YFA1103803National Natural Science Foundation of China 32370883National Science and Technology Innovation 2030 Grants of China 2021ZD0200900State Key Laboratory Special Fund 2060204
6 · The paper itself

Abstract

Specific neurotrophic signaling by Trk receptors relies on the selective recruitment of downstream adaptors such as Dok5 and Dok6, yet the structural basis underlying this selectivity has remained unresolved. Here, we elucidate the principles governing Trk-Dok specificity by integrating structural prediction with biochemical validation. Comparative analysis of AlphaFold3-predicted complexes reveals that the intracellular domains of Trk dimers exhibit model-based interpretation, matching the distinct pocket architectures of Dok5 and Dok6. Ligand-induced phosphorylation exposes critical Trk tyrosine residues, enabling high-affinity engagement by adaptor PTB domains. We identify a conserved interaction hotspot centered on Trk Tyr515/516 and Dok Tyr187 that anchors this recognition. Crucially, co-immunoprecipitation assays validate that the C-terminal domains of Dok proteins exert modulatory control via steric hindrance, a finding consistent with our structural model. Collectively, our study establishes spatial complementarity and phosphorylation-dependent exposure of docking sites as key principles governing Trk-Dok signaling specificity, providing new structural insights into neurotrophin signaling and its potential therapeutic modulation.

Indexed as

Adaptor Proteins, Signal TransducingReceptor, trkAAmino Acid SequenceAnimalsBinding SitesHumansModels, MolecularMolecular Docking SimulationPhosphorylationProtein BindingSignal TransductionAdaptor Proteins, Signal TransducingReceptor, trkADok5/Dok6Neurotrophin signalingPhosphorylation-dependent bindingStructural specificityTrk receptors

Identifiers

PMID42332721
PMCPMC13543597

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.